Bowel Management Systems Market Size, Share & Trends Analysis Report By Type (Colostomy Bags, Irrigation Systems, Nerve Modulation), By Patient Type (Adult, Pediatric), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Bowel Management Systems Market Trends

The global bowel management systems market size was valued at USD 1.73 billion in 2023 and is projected to grow at a CAGR of 3.4% from 2024 to 2030. This growth is attributed to the increasing prevalence of bowel-related disorders and conditions, such as inflammatory bowel disease, fecal incontinence, and colorectal cancer. In addition, the growing geriatric population, who are more susceptible to bowel dysfunction, is also contributing to market growth. Furthermore, technological advancements in bowel management devices, including improved irrigation systems, ostomy bags, and nerve modulation devices, enable more effective treatment options and drive adoption.

Bowel management is a significant and often time-consuming issue for increasing cases of patients with spinal cord injury. However, across the world, the elderly population is the most rapidly growing section, leading to end with having severe problems. Children with spina bifida often face bowel-related challenges, such as constipation and incontinence, due to various factors. Neurological abnormalities associated with the condition can lead to a lack of bowel control, weak abdominal muscles, and reduced physical activity. Furthermore, dietary factors, including insufficient fiber intake, contribute to the development of constipation. As these individuals grow older, they may experience age-related changes in bowel function, which can exacerbate existing issues or introduce new complications.

In addition, these are temporary containment devices designated for disabled or immobilized incontinent patients with less or no bowel control, having a liquid or semi-liquid stool, and persistent diarrhea. In addition, the increasing geriatric population, growth in target patient volumes, rising gastrointestinal diseases, pelvic floor dysfunction, and accessibility of technologically enhanced bowel management systems with favorable conditions of reimbursement in various countries result in market growth.

Furthermore, the increasing elderly population boosts the demand for efficient bowel management. The management preferences include oral and/or anal medication, digital stimulation, or manual evacuation; hence, the rising prevalence of fecal incontinence, pelvic floor dysfunctions, and age-related weaknesses of muscle results in market growth for bowel management system market across the world.

Type Insights

The colostomy bags dominated the market and accounted for the largest revenue share of 45.2% in 2023. This growth is attributed to the rising prevalence of colorectal cancer, inflammatory bowel diseases like Crohn's disease and ulcerative colitis, and the growing geriatric population, who are more susceptible to these conditions, are major drivers. In addition, the technological advancements in colostomy bags, such as sensors to detect leakage and improved designs for patient comfort, enable better treatment options and drive adoption. Increased patient awareness, strong acceptance of developed products, and new investments in R&D and manufacturing are further propelling the growth of the colostomy bags market globally.

The nerve modulation devices are projected to grow at a CAGR of 4.7% over the forecast period. This growth is driven by the increasing prevalence of bowel disorders, such as fecal incontinence, which has heightened the demand for effective treatment options. Additionally, the rapidly aging population, which is more susceptible to bowel dysfunction, is contributing to market expansion. In addition, technological advancements in nerve modulation devices, including improved efficacy and patient comfort, are also significant drivers. Furthermore, favorable reimbursement policies in developed regions enhance accessibility, encouraging healthcare providers to adopt these innovative solutions for bowel management.

Patient Type Insights

Adult patients led the market and accounted for the largest revenue share of 67.9% in 2023. This growth is attributed to the rising prevalence of colorectal cancer; individuals with symptoms of inability to control bowel movements, inadequate emptying, or chronic constipation benefit from bowel management systems. This prevents constipation and decreases unpredictable elimination. In addition, patient awareness, rising implementation of bowel management systems, increasing investments in product development and innovation, well-established healthcare infrastructure, and wide adoption of developed products are the key factors for the market growth.

The pediatric patient segment is expected to grow at a CAGR of 3.2% in the forecast period. Major factors for the increase in pediatric sections are emerging cases of children with spina bifida (SB) dealing with bowel problems nowadays, such as constipation and incontinence. Other aspects are advancements in healthcare technology, and research have improved the understanding and treatment of pediatric bowel problems, such as short bowel syndrome (SBS) and inflammatory bowel disease (IBD). Moreover, innovations in enteral and parenteral nutrition have enhanced the ability to assist pediatrics with severe bowel dysfunction, promoting better growth and development outcomes.

End Use Insights

The home care segment held the largest revenue share, 58.4%, in 2023, owing to the significant usage and rising adoption of bowel management systems in home care settings. In addition, the requirement for device replacement regularly and the rising prevalence of chronic disorders drive the segment's growth.

Hospitals and ambulatory surgery centers are expected to grow at a CAGR of 3.3% over the projected years. This growth is attributed to the technological advancements for treatment for bowel management systems procedures and digital imaging have enabled complex surgeries to be performed in ambulatory centers, which were previously conducted in hospitals. This shift is backed by the cost-effectiveness and efficiency of ambulatory surgery centers, offering high-quality care at lower costs. In addition, the rising prevalence of chronic disorders demanding surgical interventions boosted the demand for both hospitals and ambulatory surgery centers.

Regional Insights & Trends

North America bowel management systems market dominated the global market and accounted for the largest revenue share of 36.1% in 2023. This growth is attributed to the rising prevalence of bowel disorders, particularly among the aging population. In addition, increased awareness of bowel management options and the availability of advanced products enhance adoption rates. Furthermore, a well-established healthcare infrastructure and favorable reimbursement policies facilitate access to these systems. The presence of major market players and ongoing innovations in product development further propel the expansion of this market segment in the region.

U.S. Bowel Management Systems Market Trends

The bowel management systems market in the U.S. dominated the North American market and accounted for the largest revenue share of 77.8% in 2023. The primary drivers for the U.S. market include improved healthcare infrastructure, rising intestinal management system adoption, rising patient awareness, and widespread acceptance of enhanced products, which are major elements ensuring the region's dominance.

Asia Pacific Bowel Management SystemsMarket Trends

Asia Pacific bowel management systems market is expected to grow at a CAGR of 3.5% over the forecast years. The growing awareness of its treatment in regions of China, India, Japan, and other countries influenced the market expansion. Furthermore, the aging population of the Asian countries mainly drives the market growth.  

The bowel management systems market in China is expected to grow substantially over the forecast years owing to the large targeted patient population, increased awareness of improved internal bowel management systems, mounting demand for healthcare infrastructure, a surge in hospitals in the country, robust R&D sector expansion, and increase in healthcare reforms.

The India bowel management systems market is expected to experiencerapid growth over the projected years. This growth is expected to be driven by the increasing population and disorders associated with constipation and incontinence. Furthermore, the growing number of hospitals in emerging countries and the rising demand for healthcare infrastructure are the primary factors contributing to the market growth.

Europe Bowel Management Systems Market Trends

Europe bowel management systems market is expected to witness significant growth in the global market over the forecast years. This growth is driven by the rapid rise in the geriatric demographic and a growing patient population requiring effective bowel management solutions to further fuel market expansion. Furthermore, favorable reimbursement policies in many European countries improve access to these systems, promoting their adoption in both clinical and home care settings.

The bowel management system market in the UK is led by the rising occurrence of bowel disorders among citizens, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), which has uplifted the demand for effective management solutions. The aging population is another crucial factor, as older people are more prone to bowel dysfunctions, necessitating advanced management systems. Furthermore, technological advancements in bowel management products, including more efficient and patient-friendly devices, have also contributed to market growth.

Key Bowel Management Systems Company Insights

Some of the key companies in the bowel management systems market include Convatec Inc., BD, ProSys International Ltd, Suzhou Shenyun Medical Equipment Co., Ltd, Coloplast Corp, Consure Medical., Axonics, Inc., SAYCO PTY LTD; in the market & are focusing on continuous development and innovation to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

• Welland Medical Ltd. manufactures essential healthcare equipment. They specialize in developing and manufacturing stoma care appliances and accessories. Moreover, they offer mobility healthcare equipment to assist day-to-day living, such as walking frames, three-wheeled walkers, ramps, rollators, and other significant medical equipment.

• Convatec is a global medical products and technologies company that specializes in solutions for managing chronic conditions. The company holds leading market positions in several key areas, including advanced wound care, ostomy care, continence and critical care, and infusion care. Convatec's product portfolio encompasses a wide range of products designed to improve patient outcomes and reduce the total cost of care.

Recent Developments

• In January 2024, Axonics, Inc. entered into a definitive agreement for acquiring by Boston Scientific Corporation for USD 71 in cash per share, representing an equity value of approximately USD 3.7 billion. This deal marked Boston Scientific's entry in sacral neuromodulation and is the progressive in efforts to upward its urology business.

• In July 2023, Coloplast acquired a rapidly growing company in the biologics wound care sector, Kerecis, for up to $1.3 billion, including an upfront payment of $1.2 billion. This strategic acquisition aims to enhance Coloplast's presence in the advanced wound care market, particularly in the U.S. Kerecis, known for its innovative fish skin technology, is expected to significantly contribute to Coloplast's long-term growth, raising its organic growth guidance to 8-10%.

Bowel Management Systems Market Report Scope

Global Bowel Management Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global bowel management systems market report based on type, patient type, end use, and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Colostomy Bags

  • Irrigation Systems

  • Nerve Modulation Devices

  • Others

• Patient Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Adult

  • Pediatric

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Home Care

  • Hospitals and Ambulatory Surgery Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait